Recommended Global Surgery Webinars & Conferences
Europe & UK
Asia Pacific & Middle East
Canada
Neurosurgery 2025
About Conference
Join us for the 17th International Conference on Neurosurgery and Neuroscience, scheduled for August 25-26, 2025, in the vibrant city of London, UK. Under the theme "Global Neurosurgery: Bridging Gaps in Healthcare Access", this conference offers a premier platform to delve into the latest advancements and challenges in neurosurgery and neuroscience.
This event will bring together a diverse group of professionals, including neurosurgeons, neurologists, neuroscientists, researchers, healthcare practitioners, students, and industry leaders. It provides an exceptional opportunity to network, share knowledge, and explore innovative solutions to address disparities in global neurosurgical care.
Why Attend?
Attending this conference will keep you at the forefront of developments in neurosurgical techniques, neuroscience research, and healthcare innovation. Gain insights from world-renowned experts, participate in interactive sessions, and explore cutting-edge technologies. Whether you’re looking to enhance your knowledge, build professional connections, or contribute to impactful discussions, this conference is your gateway to achieving these goals. Experience the perfect blend of learning and culture in London, a global hub of history, science, and medical excellence. Don’t miss this opportunity to make meaningful contributions to the field of neurosurgery and neuroscience.
Sessions/Tracks
Advancements in neurosurgery have revolutionized the treatment of complex neurological conditions, offering innovative solutions for enhanced precision and patient outcomes. Advanced techniques in neurosurgery focus on minimally invasive approaches, cutting-edge imaging technologies, and robotics-assisted procedures. These methods aim to reduce surgical risks, improve recovery times, and achieve better clinical results for conditions such as brain tumors, aneurysms, and spinal disorders. Key advancements include neuronavigation systems that allow surgeons to visualize the brain in real-time, ensuring unparalleled accuracy during operations. Stereotactic techniques, combined with advanced imaging modalities like intraoperative MRI and CT, facilitate precise targeting of abnormalities while minimizing damage to surrounding tissues. Robotic-assisted neurosurgery further enhances surgical dexterity and control, particularly in intricate brain and spine surgeries.
The management of brain tumors has seen remarkable advancements, transforming the prognosis and quality of life for patients. Innovations in brain tumor management focus on early diagnosis, precision treatment, and minimally invasive techniques, significantly enhancing outcomes. Cutting-edge imaging technologies, such as advanced MRI and PET scans, enable detailed visualization of tumors, ensuring accurate diagnosis and treatment planning. Precision medicine has taken center stage, with therapies tailored to the genetic profile of individual tumors. Molecular and genomic profiling provides insights into tumor behavior, guiding targeted therapies that minimize side effects while maximizing efficacy. Immunotherapy, which harnesses the body’s immune system to fight cancer, has emerged as a promising approach, offering hope for cases resistant to traditional treatments. Surgical advancements include the use of intraoperative imaging and fluorescence-guided surgery, enabling neurosurgeons to remove tumors with exceptional precision. Non-invasive options like stereotactic radiosurgery and proton beam therapy deliver focused radiation to tumors, sparing healthy brain tissue and reducing complications.
Spinal cord injuries (SCI) represent a critical medical challenge, often leading to profound physical and emotional consequences. Effective diagnosis and treatment are pivotal in mitigating the impact of these injuries and improving patient outcomes. Advances in diagnostic techniques, such as high-resolution MRI and CT scans, have revolutionized the early detection of spinal cord damage. These imaging modalities provide detailed insights into the extent of injury, guiding immediate and long-term treatment strategies. Treatment for SCI encompasses a multidisciplinary approach aimed at preserving neurological function and enhancing recovery. Acute management involves immobilization, timely surgical interventions, and the use of neuroprotective agents to limit secondary damage. Emerging therapies, including stem cell transplantation and gene therapy, show promise in promoting nerve regeneration and functional recovery. Rehabilitation plays a crucial role in the long-term management of SCI. Comprehensive programs that combine physical therapy, occupational therapy, and psychological support are essential for maximizing independence and quality of life. Advances in assistive technologies, such as exoskeletons and brain-computer interfaces, offer new avenues for mobility and communication.
Minimally invasive neurosurgical procedures have revolutionized the field of neurosurgery by offering advanced, patient-centered approaches to treating complex neurological conditions. These procedures utilize cutting-edge technologies, such as endoscopes, microscopes, and neuronavigation systems, to access the brain, spine, and peripheral nerves through smaller incisions. This innovative approach minimizes trauma to surrounding tissues, resulting in reduced recovery time, fewer complications, and improved surgical outcomes. Common applications of minimally invasive neurosurgery include the treatment of brain tumors, aneurysms, spinal disc herniations, and cerebrovascular disorders. Techniques such as endoscopic skull base surgery, stereotactic radiosurgery, and minimally invasive spine surgery enable surgeons to perform complex interventions with enhanced precision. The use of advanced imaging and real-time intraoperative monitoring further ensures the safety and accuracy of these procedures. The benefits of minimally invasive approaches extend beyond physical outcomes. Patients often experience less pain, shorter hospital stays, and faster returns to daily activities, significantly improving their overall quality of life. As technology continues to evolve, the scope of minimally invasive neurosurgery is expanding, with promising developments in robotic-assisted procedures and 3D navigation systems.
Pediatric neurosurgery has seen significant advancements in recent years, driven by innovations in technology, surgical techniques, and interdisciplinary approaches. These advancements are transforming the management of neurological disorders in children, ensuring improved outcomes and quality of life. Key areas of progress include minimally invasive surgical techniques, which reduce operative risks and recovery times. Endoscopic approaches for conditions like hydrocephalus and craniosynostosis have become increasingly refined, offering effective solutions with minimal disruption to developing tissues. Innovations in imaging technologies, such as intraoperative MRI and 3D navigation systems, enhance precision and enable real-time monitoring during complex procedures. The management of pediatric brain tumors has also evolved with the integration of molecular biology and targeted therapies, allowing for more personalized treatment plans. Advances in the understanding of congenital malformations, epilepsy, and spinal disorders have led to tailored surgical interventions that align with the unique anatomical and physiological needs of pediatric patients. Additionally, interdisciplinary collaboration among neurosurgeons, neurologists, and pediatric specialists has been instrumental in developing holistic treatment approaches. Rehabilitation techniques, such as neuroplasticity-driven therapies, further support post-surgical recovery and long-term development.
Advancements in neuroimaging and diagnostic technologies have revolutionized the field of neuroscience, enabling earlier detection, precise diagnosis, and personalized treatment of neurological conditions. These breakthroughs are reshaping clinical practices and improving patient outcomes by providing unprecedented insights into brain structure and function. Modern imaging techniques, such as functional MRI (fMRI) and diffusion tensor imaging (DTI), offer detailed views of neural pathways and real-time brain activity. These tools are invaluable for understanding complex disorders like epilepsy, traumatic brain injury, and neurodegenerative diseases. Positron emission tomography (PET) and advanced CT scans complement these methods by visualizing metabolic and structural changes with remarkable accuracy. Recent innovations, such as high-field strength MRI (7T MRI), allow for the visualization of minute brain abnormalities previously undetectable. Artificial intelligence and machine learning algorithms are increasingly integrated into neuroimaging workflows, enhancing the speed and accuracy of diagnosis while identifying patterns that might elude human analysis. These breakthroughs also have applications in surgical planning, enabling neurosurgeons to map critical brain regions and minimize risks during operations. Additionally, neuroimaging plays a crucial role in monitoring the progression of diseases like Alzheimer’s and Parkinson’s, guiding therapeutic decisions.
Functional neurosurgery and deep brain stimulation (DBS) are innovative approaches that have transformed the treatment of various neurological disorders, offering significant relief to patients suffering from conditions that were previously difficult to manage. These advanced techniques are at the forefront of modern neurosurgery, particularly for movement disorders such as Parkinson’s disease, essential tremor, dystonia, and obsessive-compulsive disorder (OCD). Deep brain stimulation involves the implantation of a device that sends electrical impulses to specific areas of the brain, modulating abnormal brain activity and improving symptoms. It has shown remarkable success in reducing tremors, rigidity, and motor fluctuations in Parkinson’s disease patients, enhancing their quality of life. DBS is also increasingly explored for its potential to treat psychiatric disorders and chronic pain. Functional neurosurgery, which includes procedures like stereotactic surgery and ablative techniques, aims to restore normal function by targeting specific brain regions involved in disease processes. These surgeries are performed with high precision, often guided by advanced neuroimaging techniques, minimizing risks and improving outcomes.
Traumatic brain injury (TBI) is a critical condition that can result in long-term physical, cognitive, and emotional impairments. Effective management of TBI requires a multidisciplinary approach that combines timely diagnosis, advanced treatment strategies, and rehabilitation to optimize outcomes and improve quality of life for patients. The management of TBI begins with immediate stabilization, including ensuring airway protection, maintaining adequate oxygenation, and managing intracranial pressure (ICP) to prevent secondary brain injury. Neuroimaging techniques, such as CT scans and MRIs, play a crucial role in assessing the extent of brain damage, guiding treatment decisions, and monitoring recovery. Surgical interventions, including decompressive craniectomy and hematoma evacuation, may be required for patients with severe TBI to alleviate pressure on the brain and prevent further injury. Additionally, advancements in neuroprotective therapies, such as hypothermia treatment and pharmacological interventions, are being explored to minimize secondary injury and promote recovery. Post-acute care involves a comprehensive rehabilitation program, addressing motor, cognitive, and psychological impairments. Ongoing research is focused on developing more effective treatment protocols, personalized care plans, and neurostimulation techniques to support TBI patients in their recovery journey.
Neurosurgical oncology focuses on the surgical treatment of brain and spinal tumors, with advancements in technology and techniques revolutionizing the field. As brain and spinal tumors are complex and require precise interventions, emerging therapies are continually improving treatment outcomes and patient quality of life. Recent innovations in neurosurgical oncology include the use of intraoperative imaging systems like MRI and CT scans, enabling surgeons to visualize tumors in real-time during surgery. This allows for more precise tumor resection, reducing the risk of damage to surrounding healthy tissue and improving recovery times. Additionally, advancements in navigation systems and robotic surgery are enhancing surgical precision and minimizing complications. Emerging therapies in neurosurgical oncology also involve targeted treatments and immunotherapies that aim to fight tumors more effectively. For instance, molecularly targeted therapies, which target specific genetic mutations, and immune checkpoint inhibitors, which help the immune system recognize and attack tumor cells, are showing promise in clinical trials. Furthermore, the integration of radiofrequency ablation and focused ultrasound provides non-invasive treatment options for inoperable tumors. These cutting-edge therapies are expanding the arsenal of treatment options for patients with brain and spinal tumors.
Neurovascular surgery focuses on treating disorders related to blood vessels in the brain and spine, such as aneurysms, arteriovenous malformations (AVMs), and strokes. Despite significant advances in surgical techniques, neurovascular surgery remains one of the most complex and high-risk areas of neurosurgery due to the delicate nature of the blood vessels and the potential for severe complications. One of the major challenges in neurovascular surgery is the precise localization and treatment of vascular lesions, especially in critical areas of the brain. Advanced imaging technologies, such as 3D angiography, magnetic resonance imaging (MRI), and functional MRI, are helping surgeons visualize these lesions in greater detail, allowing for more accurate diagnosis and planning. Another challenge is managing the risk of complications, such as bleeding, stroke, or post-operative neurological deficits. To mitigate these risks, there has been a growing emphasis on minimally invasive techniques, such as endovascular procedures, where surgeons access the blood vessels through small incisions or catheters, reducing trauma and recovery time.
Neuropharmacology is the study of how drugs affect the nervous system, aiming to develop treatments for neurological and psychiatric disorders. This field has seen significant advancements, particularly in the development of therapies targeting diseases such as Alzheimer's, Parkinson's, epilepsy, and multiple sclerosis. Neuropharmacological research focuses on understanding the molecular mechanisms of the brain and nervous system to create more effective and targeted therapies with fewer side effects. One of the key challenges in neuropharmacology is the blood-brain barrier (BBB), which limits the delivery of therapeutic agents to the brain. Researchers are exploring innovative drug delivery systems, such as nanoparticles, to overcome this barrier and improve drug efficacy. Furthermore, advancements in gene therapy and personalized medicine hold the potential to revolutionize neuropharmacology by offering treatments tailored to individual genetic profiles.
Brain-Computer Interfaces (BCIs) and neural prosthetics are groundbreaking technologies that establish direct communication between the brain and external devices, offering new hope for individuals with neurological impairments. BCIs detect brain signals and translate them into commands to control devices such as prosthetic limbs, wheelchairs, and even communication tools, thus improving the quality of life for patients with conditions like paralysis, stroke, and ALS. Neural prosthetics are devices designed to replace or augment lost brain functions, including cochlear implants for hearing restoration and retinal implants for vision. These technologies are advancing rapidly, driven by innovations in neuroscience, robotics, and material science. Researchers are also exploring ways to enhance the integration between the brain and prosthetic devices to provide more natural, intuitive control.
Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and Huntington's disease, are characterized by the progressive degeneration of the brain's structure and function, leading to debilitating symptoms. While medical and pharmacological treatments are commonly used, surgical interventions have emerged as critical options for managing these conditions, especially in advanced stages. Surgical approaches for neurodegenerative disorders focus on alleviating symptoms, improving function, and slowing disease progression. Deep brain stimulation (DBS) is one of the most promising surgical interventions, particularly for Parkinson’s disease. DBS involves implanting electrodes in specific brain regions to regulate abnormal neural activity, helping control motor symptoms such as tremors and rigidity. Similarly, in Alzheimer's disease, certain surgical techniques aim to restore cognitive function or provide symptomatic relief.
The integration of robotics in neurosurgery has revolutionized the field, enhancing precision, reducing complications, and improving patient outcomes. Robotic-assisted surgery allows neurosurgeons to perform highly intricate procedures with greater accuracy and minimal invasiveness, reducing human error and the physical limitations of traditional methods. The future of robotics in neurosurgery promises to further transform the landscape with advancements in artificial intelligence (AI), machine learning, and improved robotic systems. AI-driven robotic platforms are expected to enhance surgical planning, real-time intraoperative decision-making, and post-operative monitoring, offering highly personalized treatment strategies for patients. Additionally, the continuous development of minimally invasive robotic systems will allow for even more precise interventions with smaller incisions, reduced recovery times, and fewer complications.
Cognitive neuroscience is a multidisciplinary field that explores the intricate relationship between the brain's structure, function, and behavior. Through the study of how neural processes underlie cognition, perception, and emotion, cognitive neuroscience aims to understand how the brain enables complex functions such as memory, language, attention, and decision-making. Brain mapping plays a vital role in this endeavor, utilizing advanced neuroimaging techniques like functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and electroencephalography (EEG) to visualize and study brain activity. These tools allow researchers and clinicians to map the brain's activity during specific tasks or cognitive processes, revealing the areas involved and how they interact.
Epilepsy surgery is a critical option for patients whose seizures cannot be controlled by medication. It offers a potential cure or significant reduction in seizure frequency, improving the quality of life for many individuals with drug-resistant epilepsy. Over the years, advancements in surgical techniques and diagnostic tools have significantly improved outcomes for epilepsy patients. Innovations in epilepsy surgery include the use of highly advanced imaging techniques, such as functional MRI (fMRI) and magnetoencephalography (MEG), which help identify the precise area of the brain responsible for seizure activity. These technologies allow for more accurate pre-surgical mapping, reducing the risk of complications and improving surgical success rates. Furthermore, minimally invasive techniques, including laser ablation surgery and stereotactic radiosurgery, have emerged, offering patients faster recovery times, reduced hospital stays, and fewer complications compared to traditional open surgery.
Neurosurgical critical care is an essential aspect of neurosurgery, focusing on the management of patients who have undergone complex brain and spinal surgeries. The goal is to optimize recovery, prevent complications, and ensure the best possible outcomes for patients during the postoperative period. This area of care involves continuous monitoring, early detection of complications, and timely intervention. Advancements in neurosurgical critical care have led to improved patient outcomes, particularly in areas such as brain trauma, stroke, and spinal cord injuries. Monitoring techniques, such as intracranial pressure (ICP) measurement, neuroimaging, and hemodynamic monitoring, have revolutionized patient management in critical care settings. These tools help healthcare professionals closely monitor brain function and detect issues such as brain swelling, bleeding, or infection. Moreover, advancements in recovery protocols, including early mobilization and rehabilitation, have significantly reduced recovery time and improved long-term outcomes for neurosurgical patients. The role of multidisciplinary teams, including neurologists, neurosurgeons, intensivists, and rehabilitation specialists, is vital in coordinating care and providing comprehensive support throughout the recovery process.
Access to neurosurgical care remains a significant challenge in many parts of the world, particularly in low- and middle-income countries. Limited availability of trained neurosurgeons, inadequate healthcare infrastructure, and financial barriers create disparities in the provision of essential neurosurgical services. These challenges result in delayed diagnoses, poor treatment outcomes, and higher mortality rates, especially in rural and underserved areas. A key factor contributing to these disparities is the lack of specialized training programs and neurosurgical facilities in many regions. Additionally, the high cost of neurosurgical procedures, including surgery, rehabilitation, and follow-up care, makes them unaffordable for large portions of the population, further limiting access to necessary care. Global efforts to address these disparities include initiatives to improve neurosurgical education and training, increase awareness of the importance of neurosurgery in healthcare, and develop cost-effective models of care. Collaborations between governments, healthcare organizations, and international institutions are essential in promoting equitable access to neurosurgical care.
Artificial Intelligence (AI) is rapidly transforming the landscape of neuroscience research by enhancing the ability to analyze complex data, identify patterns, and make predictions with unprecedented accuracy. In recent years, AI technologies, particularly machine learning and deep learning algorithms, have been applied to various aspects of neuroscience, ranging from neuroimaging to neurogenomics, offering new insights into brain function and neurological disorders. AI is being utilized to process and interpret massive amounts of brain imaging data, such as MRI and fMRI scans, with remarkable efficiency. These tools can detect subtle abnormalities that may be overlooked by the human eye, helping in the early diagnosis of conditions like Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Furthermore, AI models are improving the understanding of brain connectivity and functionality, aiding in the development of personalized treatments and therapies. AI is also revolutionizing drug discovery in neuroscience, enabling researchers to predict how certain compounds will interact with the brain, expediting the development of targeted therapies for neurological disorders. As these technologies continue to evolve, AI holds great promise in advancing our understanding of the brain, improving diagnostics, and driving innovation in neurosurgery and neuroscience research.
Neurosurgery, given its complexity and the high-stakes nature of procedures involving the brain and nervous system, raises numerous ethical and legal questions. Surgeons must navigate a delicate balance between offering life-saving treatments and respecting the autonomy, rights, and wishes of patients. Ethical considerations in neurosurgery revolve around informed consent, patient autonomy, and the management of risks associated with highly invasive procedures. Informed consent is a critical issue, as patients must fully understand the potential risks, benefits, and alternatives to surgery. Ethical dilemmas often arise when patients are unable to communicate their preferences due to cognitive impairment or neurological disorders. In such cases, the responsibility falls on healthcare providers to act in the best interests of the patient while adhering to legal guidelines. Legal aspects of neurosurgery include malpractice, negligence, and liability concerns. Neurosurgeons must be well-versed in the legal frameworks that govern their practice, including maintaining accurate medical records, ensuring that surgeries are justified, and providing care in accordance with established standards.
Market Analysis
The field of neurosurgery and neuroscience has witnessed significant advancements over the past decade, driven by cutting-edge technological innovations, increasing investments in research and development, and an aging global population. As the demand for neurological care grows, the market for neurosurgery and neuroscience is expected to experience robust growth in the coming years. In this analysis, we will explore the current market trends, emerging technologies, and the growth prospects in the field.
Market Overview
The global neurosurgery market was valued at approximately $12 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2028. This growth is primarily attributed to the rising prevalence of neurological disorders such as brain tumors, spinal cord injuries, neurodegenerative diseases (Alzheimer’s, Parkinson’s), and stroke. As the world’s population ages, the incidence of these diseases is expected to rise, further driving the demand for neurosurgical procedures. In addition to demographic factors, the increasing adoption of advanced technologies, such as robotics, neuroimaging, and minimally invasive techniques, is playing a crucial role in shaping the future of neurosurgery. Furthermore, the growing awareness of neurological health and the availability of specialized treatments are increasing the number of patients seeking surgical and non-surgical interventions.
Key Market Drivers
Technological Advancements: Innovations in neuroimaging, robot-assisted surgery, and neural prosthetics are transforming the landscape of neurosurgery. Advanced imaging technologies, including functional MRI and PET scans, allow surgeons to visualize the brain in real-time, improving surgical precision and outcomes. The introduction of robotic systems for neurosurgery, such as the CyberKnife and Da Vinci surgical systems, allows for less invasive procedures with reduced recovery times and improved accuracy.
Growing Prevalence of Neurological Disorders: The global burden of neurological diseases, including stroke, brain cancer, dementia, epilepsy, and traumatic brain injuries, continues to rise. The World Health Organization (WHO) estimates that neurological disorders affect more than 1 billion people worldwide. The aging population, especially in developed countries, is a major contributing factor, with a rise in diseases like Parkinson’s and Alzheimer’s, both of which have a significant impact on patients' quality of life and require advanced neurosurgical treatments.
Rising Investments in Neuroscience Research: Governments and private entities are investing heavily in neuroscience research to understand the underlying causes of neurological disorders and develop new treatments. The National Institutes of Health (NIH) and other global research organizations are funding numerous projects focused on brain-related conditions, leading to the development of new therapies and diagnostic tools. This influx of capital is fostering a collaborative environment between academia, industry, and healthcare providers.
Minimally Invasive Surgery: The shift toward minimally invasive neurosurgery is another key factor driving market growth. Procedures like endoscopic brain surgery, stereotactic radiosurgery, and keyhole surgery offer reduced trauma, faster recovery times, and fewer complications compared to traditional open surgeries. This trend is attracting both patients and healthcare providers, as it significantly lowers the cost of care and improves surgical outcomes.
Emerging Trends and Technologies
Artificial Intelligence and Machine Learning: The integration of artificial intelligence (AI) and machine learning (ML) in neurosurgery and neuroscience research holds great promise for improving patient outcomes. AI-powered algorithms are being developed for early diagnosis, risk prediction, and surgical planning. These tools can analyze medical images, detect abnormalities in brain scans, and predict potential complications during surgeries, leading to more accurate diagnoses and treatment plans.
Neurostimulation and Deep Brain Stimulation (DBS): Neurostimulation technologies, particularly Deep Brain Stimulation (DBS), are revolutionizing the treatment of neurological disorders such as Parkinson’s disease, dystonia, and epilepsy. DBS involves implanting electrodes into specific regions of the brain to regulate abnormal activity. The market for neurostimulation devices is projected to grow significantly, driven by ongoing research into new applications, such as treating depression and chronic pain.
Gene Therapy and Regenerative Medicine: Research into gene therapy and stem cell therapies is advancing rapidly, with the potential to treat previously untreatable neurological disorders. Stem cell-based therapies for spinal cord injuries and neurodegenerative diseases offer new hope for patients who would have otherwise been reliant on lifelong care. These therapies are expected to become a major segment within the neurosurgery and neuroscience markets.
Robotics and Precision Medicine: Robotic systems and precision medicine are expected to become integral components of neurosurgery in the future. Robotic systems enable greater accuracy, reduce human error, and improve patient recovery times. Precision medicine, which tailors treatments to an individual’s genetic profile, is being explored for its potential to improve outcomes in treating neurological diseases.
Regional Market Insights
North America: The North American neurosurgery market holds the largest share, driven by advanced healthcare infrastructure, high healthcare expenditure, and increasing awareness of neurological diseases. The U.S. is a global leader in medical technology and innovation, particularly in robotics and neuroimaging.
Europe: Europe is another significant market, with countries such as Germany, the UK, and France investing heavily in neuroscience research and adopting advanced neurosurgical techniques. The growing elderly population and the rising incidence of neurodegenerative diseases are major factors contributing to market expansion in this region.
Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth in the neurosurgery market due to an aging population, improved healthcare infrastructure, and increasing disposable incomes. Countries such as Japan, China, and India are making substantial investments in healthcare technologies, improving accessibility to advanced neurosurgical treatments.
Latin America and Middle East: Both regions are witnessing increasing demand for advanced neurosurgical treatments, driven by economic growth, better healthcare facilities, and improving healthcare awareness. Healthcare investments in countries like Brazil, Saudi Arabia, and the UAE are expected to further drive market growth.
Past Conference Report
Neurosurgery 2023
On behalf of ConferenceSeries it is our pride and privilege to invite all the participants from all around the world to attend “16th International Conference on Neurosurgery and Neuroscience’’ held during November 15-16, 2023, Barcelona, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Neurosurgery 2023 is an annual meeting which gathers Neurosurgeons as well as Neurology researchers to explore the future of the Neurosurgery and Neurological disorders which offers you to pay attention to distinct factors of new ideas and developments in Neurology and Neurosurgery to enhance public health and well-being.
Neurosurgery 2023 participants include professors, researchers, physicians, business delegates, scientists, students all over the world.
Significance and scope?
Nearly 90% of the world’s population, suffer from Neurological disorders, from Alzheimer and Parkinson disease, strokes, multiple sclerosis and epilepsy to migraine, brain injuries and neuroinfections, with some 6.8 million dying each year.
Who will attend?
Neurosurgery 2023 main aim is to bring Neurologists and Directors, Stroke Specialists, Neurology researchers, Neuroscientists, Specialists, Researchers, Professors, Industrial, Experts, Neurosurgeons, Psychiatrist, Lecturers and Students and Neuroscience Therapists, Neurology organizations, societies and associations under a single roof. We truly believe that Neurosurgery 2023 in Paris will be a highly rewarding event for everyone, which will help in health enhancement and quality of life.
Past Reports Gallery
To Collaborate Scientific Professionals around the World
Conference Date August 25-26, 2025
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by